Holen Sie sich die Stockscreener-App
5.49
0.55%
0.03
Schlusskurs vom Vortag:
$5.46
Offen:
$5.54
24-Stunden-Volumen:
86,874
Relative Volume:
0.09
Marktkapitalisierung:
$134.75M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.73%
1M Leistung:
+41.86%
6M Leistung:
+52.08%
1J Leistung:
+22.27%
1-Tages-Spanne:
$5.21
$5.54
1-Wochen-Bereich:
$5.1921
$6.0699
52-Wochen-Spanne:
$1.47
$7.36
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
Firmenname
Artiva Biotherapeutics Inc
Sektor
Branche
Telefon
(858) 267-4467
Adresse
5505 MOREHOUSE DRIVE, SAN DIEGO
Compare ARTV vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
5.49 | 134.02M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.31 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
765.80 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
724.85 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.34 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.15 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-11 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-08-13 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-13 | Eingeleitet | Jefferies | Buy |
| 2024-08-13 | Eingeleitet | Needham | Buy |
| 2024-08-13 | Eingeleitet | TD Cowen | Buy |
| 2024-08-13 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Artiva Biotherapeutics Inc Aktie (ARTV) Neueste Nachrichten
Artiva Biotherapeutics Pivots to Rheumatoid Arthritis at TD Cowen, Teases 2026 RA Data Update - Yahoo Finance
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewswire
Artiva Biotherapeutics appoints Thad Huston as chief financial officer - Investing.com Australia
Artiva Biotherapeutics appoints Thad Huston as chief financial officer By Investing.com - Investing.com South Africa
Artiva Biotherapeutics Appoints Thad Huston as Chief Financial Officer - TipRanks
Artiva Biotherapeutics, Inc. Appoints Thad Huston as Principal Financial Officer and Principal Accounting Officer, Effective from February 18, 2026 - marketscreener.com
Artiva Biotherapeutics Announces Appointment of Thad Huston as Chief Financial Officer and Award of Inducement Grant - The Globe and Mail
Artiva Biotherapeutics Announces Appointment Of Thad Huston As CFO - TradingView
Artiva Biotherapeutics Announces Appointment of Thad Huston as Chief Financial Officer and Award of Inducement Grant - GlobeNewswire Inc.
Is Artiva Biotherapeutics Inc. on track to beat earningsJuly 2025 Retail & Daily Profit Maximizing Tips - mfd.ru
Artiva Biotherapeutics Inc. (ARTV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Can Artiva Biotherapeutics Inc. keep up with sector leaders2025 Institutional Moves & AI Driven Stock Movement Reports - mfd.ru
Will Artiva Biotherapeutics Inc. benefit from rate cutsJuly 2025 Weekly Recap & Consistent Profit Alerts - mfd.ru
Artiva Biotherapeutics appoints pharma veteran Elaine Sorg to board By Investing.com - Investing.com India
Earnings Miss: Does Artiva Biotherapeutics Inc. have consistent dividend growthWeekly Stock Report & Precise Trade Entry Recommendations - mfd.ru
Artiva Biotherapeutics Adds Veteran Executive Elaine Sorg to Board - The Globe and Mail
Artiva Biotherapeutics appoints pharma veteran Elaine Sorg to board - Investing.com Australia
Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors - Bitget
AtaiBeckley Appoints Michael Faerm as Chief Financial Officer - The Manila Times
Sell Signal: Is LINKBANCORP Inc a defensive stockJuly 2025 PreEarnings & High Yield Equity Trading Tips - baoquankhu1.vn
Aug Momentum: Does Artiva Biotherapeutics Inc have consistent dividend growth2025 Key Lessons & Precise Buy Zone Tips - baoquankhu1.vn
Will Artiva Biotherapeutics Inc. stock benefit from sector rotation2025 Dividend Review & Real-Time Buy Signal Notifications - mfd.ru
Can Artiva Biotherapeutics Inc. stock continue upward trendWeekly Loss Report & Free High Accuracy Swing Entry Alerts - mfd.ru
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Short Interest Down 28.5% in January - MarketBeat
Artiva Biotherapeutics, Inc. (RTVA.US) Latest News & Headlines - Longbridge
Is Artiva Biotherapeutics Inc. stock risky to hold nowJuly 2025 Momentum & Long-Term Growth Portfolio Plans - mfd.ru
Published on: 2026-02-12 04:11:50 - mfd.ru
Will Artiva Biotherapeutics Inc. outperform its industry peersPortfolio Update Report & Community Driven Trade Alerts - mfd.ru
Is Artiva Biotherapeutics Inc. stock a good pick for beginnersQuarterly Portfolio Review & AI Optimized Trading Strategy Guides - mfd.ru
Can Artiva Biotherapeutics Inc. stock outperform in a bear marketForecast Cut & Low Risk Investment Opportunities - mfd.ru
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives $19.00 Average PT from Brokerages - Defense World
ARTV Stock Price and Chart — NASDAQ:ARTV - TradingView
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Artiva Biotherapeutics executes RSU exchange for employees - MSN
Trading Action: Is Artiva Biotherapeutics Inc stock a good pick for beginnersJuly 2025 Momentum & Community Consensus Trade Signals - baoquankhu1.vn
Hedge Fund Bets: Is CFRPRB stock heavily shortedTreasury Yields & Technical Pattern Recognition Alerts - baoquankhu1.vn
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Sees Significant Decline in Short Interest - MarketBeat
Pharma News: Can AGMH outperform under higher oil pricesTrade Exit Report & Technical Entry and Exit Tips - baoquankhu1.vn
Brokers Set Expectations for ARTV FY2030 Earnings - Defense World
Income Plays: Is Artiva Biotherapeutics Inc.’s ROE strong enoughJuly 2025 Opening Moves & Weekly Chart Analysis and Trade Guides - mfd.ru
Update Report: Can Artiva Biotherapeutics Inc. outperform in the next rallyJuly 2025 Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Undervalued Penny Stocks To Consider In January 2026 - simplywall.st
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Artiva Biotherapeutics, Inc. (ARTV) and Oncolytics Biotech (ONCY) - The Globe and Mail
Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Contin - The Globe and Mail
Artiva Biotherapeutics Announces Upcoming Presentations at - GlobeNewswire
Take Profit: Is Artiva Biotherapeutics Inc part of any ETF2025 Price Targets & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Aug Catalysts: How do insiders feel about Artiva Biotherapeutics IncJuly 2025 Reactions & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Take Profit: Can Artiva Biotherapeutics Inc outperform in the next rallyWeekly Market Report & Daily Stock Trend Watchlist - baoquankhu1.vn
Wall Street Recap: Is AppTech Payments Corp Equity Warrant attractive for institutional investorsJuly 2025 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Trend Recap: Will Artiva Biotherapeutics Inc outperform its industry peers2025 Key Highlights & Accurate Intraday Trade Tips - baoquankhu1.vn
Finanzdaten der Artiva Biotherapeutics Inc-Aktie (ARTV)
Es liegen keine Finanzdaten für Artiva Biotherapeutics Inc (ARTV) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
4.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):